𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Angiotensin I converting enzyme in cerebrospinal fluid of patients with neurological diseases

✍ Scribed by Schweisfurth, H. ;Schiöberg-Schiegnitz, S. ;Kuhn, W. ;Parusel, B.

Publisher
Springer-Verlag
Year
1987
Tongue
English
Weight
479 KB
Volume
65
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Myelin basic protein in cerebrospinal fl
Myelin basic protein in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases
✍ A. Biber; D. Englert; D. Dommasch; K. Hempel 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 368 KB

Cerebrospinal fluid (CSF) from 105 patients was analyzed by radioimmunoassay for the presence of material cross-reactive with peptide 89-169 of bovine myelin basic protein (BP). In a group of 72 multiple sclerosis patients, 52 showed higher BP content than the control group, i.e. more than 2 ng/ml C

Metabolic effects of long-term angiotens
Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition
✍ R. Reneland; P.-E. Andersson; A. Haenni; H. Lithell 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 566 KB

Fifty patients with mild to moderate essential hypertension were randomized to receive either 20 mg fosinopril daily for 16 weeks or placebo for 4 weeks followed by 12 weeks of 50 mg atenolol daily. Prior to these 16 weeks there was a placebo wash-out period of 2-6 weeks. Blood pressure measurements